10 results
Search Results
2. Study: Counterfeits/fentanyl making drug use more deadly for adolescents.
- Author
-
Knopf, Alison
- Subjects
- *
HEALTH policy , *OCCUPATIONAL roles , *SAFETY , *NARCOTICS , *DISEASE clusters , *SUBSTANCE abuse , *DRUG overdose , *SOCIAL media , *FENTANYL , *CURRICULUM , *PARENTING , *HEALTH literacy , *SCHOOLS , *POLICY sciences , *DRUG counterfeiting , *DOSAGE forms of drugs , *PATIENT safety , *ADOLESCENCE - Abstract
As Scott E. Hadland, M.D., senior author of a dramatic paper published last week in the New England Journal of Medicine puts it, drug use among adolescents is not getting more common — it's at its lowest in almost 50 years. But it's getting more deadly, due to fentanyl. In "The Overdose Crisis among U.S. Adolescents," by Hadland and lead author Joseph Friedman, Ph.D., the problem is laid out clearly: After guns and car crashes, overdose (OD) deaths are now the third leading cause of death among adolescents. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. 10 options for federal opioid changes: New paper from RAND.
- Author
-
Knopf, Alison
- Subjects
- *
NARCOTIC laws , *SUBSTANCE abuse laws , *HEALTH policy , *SUBSTANCE abuse , *FEDERAL government , *HEALTH services accessibility , *INSURANCE , *NALOXONE , *GOVERNMENT regulation - Abstract
There have been many calls for federal changes to address the opioid epidemic, but one from Beau Kilmer, senior policy researcher and director of the Drug Policy Research Center at the RAND Corporation, released last week is a particularly interesting distillation that doesn't omit pros and cons for each strategy. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
4. NIDA on dramatic increase of mushroom seizures.
- Author
-
Knopf, Alison
- Subjects
- *
MUSHROOMS , *SUBSTANCE abuse , *ALKALOIDS , *HALLUCINOGENIC drugs , *SOCIAL control - Abstract
From 2017 – 2022, law enforcement seizures across the United States of mushrooms containing psilocybin increased dramatically, according to a new study funded by the National Institute on Drug Abuse (NIDA). The number of law enforcement seizures increased from 402 seizures in 2017 to 1,396 in 2022. In addition, the total weight of psilocybin mushrooms seized by law enforcement increased from 226 kg (498 lbs.) seized in 2017 compared with 844 kg (1,861 lbs.) in 2022. This analysis, published in Drug and Alcohol Dependence, was led by researchers at New York University (NYU) Langone Health in New York City, and the University of Florida, Gainesville. The data used for the analysis were collected through the High Intensity Drug Trafficking Areas (HIDTA) program, a grant program aimed at reducing drug trafficking and misuse administered by the Office of National Drug Control Policy. Though law enforcement seizures do not necessarily reflect prevalence of use, they represent an indicator of the availability of illicit drugs. "We are in the middle of a rapidly evolving cultural, media, and legal landscape when it comes to psychedelics, and we need data to help shape informed and appropriate public health strategies," said NIDA Director Nora D. Volkow, M.D., in announcing the research publication last week. "Moving forward, we must continue to track data on the availability of psychedelics, patterns in use, and associated health effects to guide efforts in promoting accurate education and reducing potential harms among people who do plan to use psychedelic drugs." Adverse effects of psilocybin mushrooms, such as "bad trips," are marked by "distorted thinking, perceptual changes, putting oneself in physical danger, and intense feelings of fear, anxiety, and confusion," according to NIDA. "People who take psychedelic drugs like psilocybin may also experience short‐term side effects such as raised blood pressure and heart rate, agitation, confusion, vomiting, or nausea, which may be severe and require medical attention." Joseph J. Palamar, Ph.D., M.P.H., associate professor at the NYU Grossman School of Medicine, co‐investigator on the NIDA‐funded National Drug Early Warning System (NDEWS), and lead author on the paper, said "Research studies suggesting its effectiveness in treating mental health issues and extensive positive media coverage may lead some people to seek 'shrooms' outside of medical contexts. People who use psilocybin outside of medical supervision need to be educated about risks associated with use." [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Report: 1115 waivers provide funds but don't ensure effective SUD care.
- Author
-
Enos, Gary
- Subjects
- *
MEDICAID law , *SUBSTANCE abuse treatment , *SUBSTANCE abuse , *MEDICAL quality control , *NARCOTICS , *HEALTH services accessibility , *REPORT writing , *ANALGESICS , *HEALTH insurance reimbursement , *QUALITY assurance , *GOVERNMENT aid , *MEDICAL needs assessment - Abstract
The primary manner by which states have been using Medicaid to expand access to substance use disorder (SUD) treatment may actually be making it more difficult for individuals to receive the services most appropriate to their needs, a newly released paper suggests. Moreover, this preferred strategy in many cases violates the law, authors with the National Health Law Program contend. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
6. Prominent researchers argue against more of the same in treatment funding.
- Author
-
Enos, Gary
- Subjects
- *
CONFLICT (Psychology) , *HEALTH services accessibility , *MEDICAL quality control , *HEALTH policy , *NARCOTICS , *PRACTICAL politics , *SUBSTANCE abuse treatment , *GOVERNMENT aid , *HEALTH insurance reimbursement , *TREATMENT programs - Abstract
An over‐reliance on federal block grants and "one‐off" funding initiatives has left the addiction treatment system under‐resourced to respond to an addiction crisis that stands to be at least as deadly as COVID‐19 during the span of the Biden administration, a trio of prominent researchers argue in a newly released policy paper. The authors suggest that the new administration and Congress should prioritize efforts to build on what they consider the most impactful developments in improving access and quality in addiction treatment, such as Medicaid expansion and parity mandates. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
7. Canada and US issue joint statement on overdoses.
- Subjects
- *
DRUG overdose , *INTERPROFESSIONAL relations , *METHADONE hydrochloride , *COVID-19 pandemic , *OPIOID abuse - Abstract
A white paper from Canada and the United States focuses on collaboration between the two countries on their commitment to deal with the overdose crisis. "Substance Use and Harms During COVID‐19 and Approaches to Federal Surveillance and Response," issued Sept. 27, states that the increase in "substance use harms and deaths" during COVID‐19 is partly due to a decrease in access to services. The white paper itself focuses on the restrictions to methadone access in the United States and says little about the Canadian rules, but they are much more lenient. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. Treatment field takes a step toward civil commitment.
- Author
-
Knopf, Alison
- Subjects
- *
SUBSTANCE abuse treatment , *SUBSTANCE abuse , *INSTITUTIONAL care , *MEDICAL ethics , *MEDICAL records , *NARCOTICS , *PRIVACY , *SELF-management (Psychology) , *RULES , *TREATMENT programs , *INVOLUNTARY hospitalization , *PATIENT autonomy , *LAW - Abstract
The article talks about the concept of civil commitment for substance use disorders (SUDs), discussing a research paper released by Hazelden Betty Ford Foundation. Topics discussed include the views of some people that addiction is a disease and its treatment should not be coerced; a paper by the U.S. National Institute on Drug Abuse (NIDA) on it; and the benefits of involuntary commitment laws for substance use disorders.
- Published
- 2017
- Full Text
- View/download PDF
9. In Case You Haven't Heard...
- Subjects
- *
CANNABIS (Genus) , *CRIMINAL justice system - Abstract
Sen. Kamala Harris (D‐California) is Democrat presidential candidate Joe Biden's pick for vice president. And although she has been pilloried by the pro‐marijuana progressives for her prosecution of marijuana cases, in fact, she was not overly aggressive in these cases, according to an article in The Mercury News. "There is no way anyone could say that she was draconian in her pursuit of marijuana cases," said Niki Solis, a high‐ranking attorney in the San Francisco Public Defender's Office during Harris' time as district attorney, the paper stated. Marijuana legalization was a centerpiece of her presidential campaign. For the Mercury News story, see https://www.mercurynews.com/2019/09/11/kamala‐harris‐prosecuting‐marijuana‐cases/. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
10. What a difference a label makes.
- Author
-
Clark, H. Westley
- Subjects
- *
ALCOHOLISM , *DENIAL (Psychology) , *MEDICAL needs assessment , *BINGE drinking - Abstract
The article discussed how a paper released by the federal Centers for Disease Control and Prevention (CDC) entitled "Prevalence of Alcohol Dependence Among US Adult Drinkers, 2009-2011" accidentally promoted heavy drinking and misconstrued diagnostic criteria for alcohol dependence. It mentions that mass media widely circulated the paper, using the familiar synonym "alcoholics" instead of "alcohol dependence" that added to denial.
- Published
- 2014
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.